Cochrane Clinical Answers - Access Denied - In women with early poor prognosis breast cancer, how does high-dose chemotherapy plus autologous bone marrow or stem cell transplantation compare with conventional chemotherapy?

Question:In women with early poor prognosis breast cancer, how does high-dose chemotherapy plus autologous bone marrow or stem cell transplantation compare with conventional chemotherapy?

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer evaluates high-dose chemotherapy plus autologous bone marrow or stem cell transplantation in women with early poor prognosis breast cancer.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.